Orphan Drug Center empowered with drug sale function.

Published: 2001-07-24 06:58:00

Updated: 2001-07-24 06:58:00

As the National Assembly passed through the revised pharmaceutical affairs law on July 18 covering detailed scope of orphan drugs and their administrative particulars, the Korea Orphan Drug Center has been upgraded as a legal entity and its official position to the public, qualifying to authorize...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK